Simple view
Full metadata view
Authors
Statistics
BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer
BacSp222 bacteriocin
FPR
inflammation
LTA
PAMP
TLR2/TLR6
Online First 2023-03-25
Objective and design BacSp222 bacteriocin is a bactericidal and proinflammatory peptide stimulating immune cells to produce selected cytokines and NO in NF-ĸB dependent manner. This study aims to identify the receptor which mediates this activity. Methods We applied fluorescently labeled BacSp222 and a confocal microscopy imaging to analyze the direct interaction of the bacteriocin with the cells. Reporter HEK-Blue cells overexpressing human toll-like receptors (TLR2, TLR4, TLR5 or TLR2/TLR1 and TLR2/TLR6 heterodimers) were stimulated with BacSp222, and then the activity of NF-ĸB-dependent secreted embryonic alkaline phosphatase (SEAP) was measured. In turn, formylated peptide receptor (FPR) or TLR2 antagonists were used to verify bacteriocin-stimulated TNF production by murine monocyte-macrophage cell lines. Results BacSp222 undergoes internalization into cells without disturbing the cell membrane. FPR antagonists do not affect TNF produced by BacSp222-stimulated murine macrophage-like cells. In contrast, BacSp222 stimulates NF-ĸB activation in HEK-Blue overexpressing TLR2 or TLR2/TLR6 heterodimer, but not TLR2/TLR1, TLR4 or TLR5 receptors. Moreover, TLR2-specific antagonists inhibit NF-ĸB signaling in BacSp222-stimulated HEK-Blue TLR2/TLR6 cells and reduce TNF release by BacSp222-treated RAW 264.7 and P388.D1. Conclusions BacSp222 is a novel ligand for TLR2/TLR6 heterodimer. By binding TLR complex the bacteriocin undergoes internalization, inducing proinflammatory signaling that employs MyD88 and NF-ĸB pathways.
| dc.abstract.en | Objective and design BacSp222 bacteriocin is a bactericidal and proinflammatory peptide stimulating immune cells to produce selected cytokines and NO in NF-ĸB dependent manner. This study aims to identify the receptor which mediates this activity. Methods We applied fluorescently labeled BacSp222 and a confocal microscopy imaging to analyze the direct interaction of the bacteriocin with the cells. Reporter HEK-Blue cells overexpressing human toll-like receptors (TLR2, TLR4, TLR5 or TLR2/TLR1 and TLR2/TLR6 heterodimers) were stimulated with BacSp222, and then the activity of NF-ĸB-dependent secreted embryonic alkaline phosphatase (SEAP) was measured. In turn, formylated peptide receptor (FPR) or TLR2 antagonists were used to verify bacteriocin-stimulated TNF production by murine monocyte-macrophage cell lines. Results BacSp222 undergoes internalization into cells without disturbing the cell membrane. FPR antagonists do not affect TNF produced by BacSp222-stimulated murine macrophage-like cells. In contrast, BacSp222 stimulates NF-ĸB activation in HEK-Blue overexpressing TLR2 or TLR2/TLR6 heterodimer, but not TLR2/TLR1, TLR4 or TLR5 receptors. Moreover, TLR2-specific antagonists inhibit NF-ĸB signaling in BacSp222-stimulated HEK-Blue TLR2/TLR6 cells and reduce TNF release by BacSp222-treated RAW 264.7 and P388.D1. Conclusions BacSp222 is a novel ligand for TLR2/TLR6 heterodimer. By binding TLR complex the bacteriocin undergoes internalization, inducing proinflammatory signaling that employs MyD88 and NF-ĸB pathways. | pl |
| dc.affiliation | Wydział Biochemii, Biofizyki i Biotechnologii : Zakład Biochemii Analitycznej | pl |
| dc.affiliation | Wydział Biochemii, Biofizyki i Biotechnologii : Zakład Biochemii Komórki | pl |
| dc.affiliation | Szkoła Doktorska Nauk Ścisłych i Przyrodniczych | pl |
| dc.contributor.author | Śmiałek-Bartyzel, Justyna - 246115 | pl |
| dc.contributor.author | Bzowska, Monika - 127507 | pl |
| dc.contributor.author | Mężyk-Kopeć, Renata - 130487 | pl |
| dc.contributor.author | Kwissa, Marcin | pl |
| dc.contributor.author | Mak, Paweł - 130230 | pl |
| dc.date.accessioned | 2023-03-27T12:35:07Z | |
| dc.date.available | 2023-03-27T12:35:07Z | |
| dc.date.issued | 2023 | pl |
| dc.date.openaccess | 0 | |
| dc.description.accesstime | w momencie opublikowania | |
| dc.description.additional | Online First 2023-03-25 | pl |
| dc.description.number | 5 | pl |
| dc.description.physical | 915-928 | pl |
| dc.description.version | ostateczna wersja wydawcy | |
| dc.description.volume | 72 | pl |
| dc.identifier.doi | 10.1007/s00011-023-01721-3 | pl |
| dc.identifier.eissn | 1420-908X | pl |
| dc.identifier.issn | 1023-3830 | pl |
| dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/309511 | |
| dc.language | eng | pl |
| dc.language.container | eng | pl |
| dc.rights | Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa | * |
| dc.rights.licence | CC-BY | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/legalcode.pl | * |
| dc.share.type | inne | |
| dc.subject.en | BacSp222 bacteriocin | pl |
| dc.subject.en | FPR | pl |
| dc.subject.en | inflammation | pl |
| dc.subject.en | LTA | pl |
| dc.subject.en | PAMP | pl |
| dc.subject.en | TLR2/TLR6 | pl |
| dc.subtype | Article | pl |
| dc.title | BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer | pl |
| dc.title.journal | Inflammation Research | pl |
| dc.type | JournalArticle | pl |
| dspace.entity.type | Publication |